The era of the "smart pharma factory" is finally bridging this divide. By integrating digital manufacturing systems, specifically the Manufacturing Execution System (MES), with the broader pharma supply chain, companies are unlocking live visibility and unprecedented responsiveness.
EAMS Onboarding for MAHs (Access, Teams, Workflows, and Day-to-Day Setup)
The critical detail most teams miss is that AMS access is OBP-based, not MAH-based and as defined by EMVO, OBPs can create users and structure them into teams to control alert visibility by market. The practical implication is that onboarding success depends on how entities, teams, market coverage, and ownership...
EMVO AMS and EAMS Explained for MAHs
The European Medicines Verification System (EMVS) only works at scale when alerts are handled quickly, consistently, and with high-quality data. A single alert at dispensing can trigger quarantine procedures, investigations, and communication with national verification organizations. When this happens across hundreds of SKUs, multiple CMOs, and many European markets, the...
EPCIS 1.2 to EPCIS 2.0 Migration Guide for Pharma Traceability Programs
A practical migration guide for pharma teams moving from EPCIS 1.2 to EPCIS 2.0 - covering what changes, what stays, and how to sequence the transition without disrupting DSCSA compliance.
Top 25 EPCIS Data Errors That Break Interoperability
The 25 most common EPCIS data errors causing DSCSA interoperability failures - from schema mismatches to missing business steps - and the prevention controls that stop them.
